915976-85-1Relevant articles and documents
SIX-MEMBERED AND SIX-MEMBERED HETEROCYCLIC COMPOUND AND USES THEREOF SERVING AS PROTEIN RECEPTOR KINASE INHIBITOR
-
Paragraph 0085; 0098-0100; 0106; 0116-0118, (2021/09/24)
Provided are a preparation and applications of a six-membered fused with six-membered heterocyclic compound, specifically, provided in the present invention is a compound as represented by formula I as follows, where the definitions of the groups are as described in the description. The compound has TRK kinase inhibiting activity and can serve as a pharmaceutical composition for treating TRK dysfunction-related diseases.
BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
-
, (2013/03/26)
Novel bridged bicyclic compounds are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antibacterial agents. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating bacterial infections and associated diseases and conditions.
TRICYCLIC COMPOUNDS AS ANTIBACTERIALS
-
Page/Page column 52-53, (2008/12/08)
Tricyclic nitrogen containing compounds of formula (I) and their use as antibacterials.
HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIBACTERIALS
-
Page/Page column 40, (2008/06/13)
Tricyclic nitrogen containing compounds of formula (I) and their use as antibacterials .
TRYCLIC NITROGEN CONTAINING COMPOUNDS AND THEIR USE AS ANTIBACTERIALS
-
Page/Page column 19-20, (2008/06/13)
Tricyclic nitrogen containing compounds of formula (I) and their use as antibacterials.